Q1 2026 earnings call recap: revenue up, AYON ramp, raised 2026 guidance to $59–$60M, margins/tariffs & FDA catalysts—read now.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results